| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |